The effects of GLP-1 receptor agonists on visceral fat and liver ectopic fat in an adult population with or without diabetes and nonalcoholic fatty liver disease: A systematic review and meta-analysis. Here, GLP1R is linked to metabolic dysfunction-associated steatotic liver disease.